Literature DB >> 12145203

Mos is not required for the initiation of meiotic maturation in Xenopus oocytes.

Aude Dupré1, Catherine Jessus, René Ozon, Olivier Haccard.   

Abstract

In Xenopus oocytes, the c-mos proto-oncogene product has been proposed to act downstream of progesterone to control the entry into meiosis I, the transition from meiosis I to meiosis II, which is characterized by the absence of S phase, and the metaphase II arrest seen prior to fertilization. Here, we report that inhibition of Mos synthesis by morpholino antisense oligonucleotides does not prevent the progesterone-induced initiation of Xenopus oocyte meiotic maturation, as previously thought. Mos-depleted oocytes complete meiosis I but fail to arrest at metaphase II, entering a series of embryonic-like cell cycles accompanied by oscillations of Cdc2 activity and DNA replication. We propose that the unique and conserved role of Mos is to prevent mitotic cell cycles of the female gamete until the fertilization in Xenopus, starfish and mouse oocytes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145203      PMCID: PMC126146          DOI: 10.1093/emboj/cdf400

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  65 in total

1.  Specificity and mechanism of action of some commonly used protein kinase inhibitors.

Authors:  S P Davies; H Reddy; M Caivano; P Cohen
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

2.  Speedy: a novel cell cycle regulator of the G2/M transition.

Authors:  J L Lenormand; R W Dellinger; K E Knudsen; S Subramani; D J Donoghue
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

3.  Mos proto-oncogene function during oocyte maturation in Xenopus.

Authors:  L M Roy; O Haccard; T Izumi; B G Lattes; A L Lewellyn; J L Maller
Journal:  Oncogene       Date:  1996-05-16       Impact factor: 9.867

4.  Biochemical and biological analysis of Mek1 phosphorylation site mutants.

Authors:  W Huang; D S Kessler; R L Erikson
Journal:  Mol Biol Cell       Date:  1995-03       Impact factor: 4.138

5.  Mos/mitogen-activated protein kinase can induce early meiotic phenotypes in the absence of maturation-promoting factor: a novel system for analyzing spindle formation during meiosis I.

Authors:  T Choi; S Rulong; J Resau; K Fukasawa; W Matten; R Kuriyama; S Mansour; N Ahn; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

6.  Evidence for two catalytically active kinase domains in pp90rsk.

Authors:  T L Fisher; J Blenis
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Microtubule and chromatin behavior follow MAP kinase activity but not MPF activity during meiosis in mouse oocytes.

Authors:  M H Verlhac; J Z Kubiak; H J Clarke; B Maro
Journal:  Development       Date:  1994-04       Impact factor: 6.868

8.  The exit of mouse oocytes from meiotic M-phase requires an intact spindle during intracellular calcium release.

Authors:  N J Winston; O McGuinness; M H Johnson; B Maro
Journal:  J Cell Sci       Date:  1995-01       Impact factor: 5.285

9.  Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes.

Authors:  A R Nebreda; J V Gannon; T Hunt
Journal:  EMBO J       Date:  1995-11-15       Impact factor: 11.598

10.  Mos is required for MAP kinase activation and is involved in microtubule organization during meiotic maturation in the mouse.

Authors:  M H Verlhac; J Z Kubiak; M Weber; G Géraud; W H Colledge; M J Evans; B Maro
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  34 in total

Review 1.  Vertebrate Reproduction.

Authors:  Sally Kornbluth; Rafael Fissore
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-10-01       Impact factor: 10.005

2.  Mechanistic studies of the mitotic activation of Mos.

Authors:  Jianbo Yue; James E Ferrell
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

3.  Redundant pathways for Cdc2 activation in Xenopus oocyte: either cyclin B or Mos synthesis.

Authors:  Olivier Haccard; Catherine Jessus
Journal:  EMBO Rep       Date:  2005-12-16       Impact factor: 8.807

4.  Vg1RBP phosphorylation by Erk2 MAP kinase correlates with the cortical release of Vg1 mRNA during meiotic maturation of Xenopus oocytes.

Authors:  Anna Git; Rachel Allison; Eusebio Perdiguero; Angel R Nebreda; Evelyn Houliston; Nancy Standart
Journal:  RNA       Date:  2009-04-17       Impact factor: 4.942

5.  Zar1 represses translation in Xenopus oocytes and binds to the TCS in maternal mRNAs with different characteristics than Zar2.

Authors:  Tomomi M Yamamoto; Jonathan M Cook; Cassandra V Kotter; Terry Khat; Kevin D Silva; Michael Ferreyros; Justin W Holt; Jefferson D Knight; Amanda Charlesworth
Journal:  Biochim Biophys Acta       Date:  2013-07-01

6.  Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.

Authors:  Karthik Arumugam; Yiying Wang; Linda L Hardy; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

Review 7.  Control of oocyte growth and meiotic maturation in Caenorhabditis elegans.

Authors:  Seongseop Kim; Caroline Spike; David Greenstein
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

8.  Signal propagation of the MAPK cascade in Xenopus oocytes: role of bistability and ultrasensitivity for a mixed problem.

Authors:  Ralf Blossey; Jean-François Bodart; Anne Devys; Thierry Goudon; Pauline Lafitte
Journal:  J Math Biol       Date:  2011-02-03       Impact factor: 2.259

9.  G2 arrest in Xenopus oocytes depends on phosphorylation of cdc25 by protein kinase A.

Authors:  Brian C Duckworth; Jennifer S Weaver; Joan V Ruderman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-11       Impact factor: 11.205

10.  Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25C.

Authors:  Eusebio Perdiguero; Marie-Jeanne Pillaire; Jean-Francois Bodart; Florian Hennersdorf; Morten Frödin; Nicholas S Duesbery; Gema Alonso; Angel R Nebreda
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.